Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 596 (ZNF596) is a protein encoded by the ZNF596 gene. It belongs to the zinc finger family of proteins, which are characterized by the presence of structural motifs that coordinate zinc ions and typically function as transcription factors within the nucleus. ZNF596 is predicted to enable DNA-binding transcription factor activity that is RNA polymerase II-specific, regulating gene expression in a sequence-specific manner. Its biological role stems from its ability to bind particular DNA regions and regulate transcription. While a paralog exists (ZFP90), direct involvement in disease is limited to possible association with Retinitis pigmentosa. Currently, ZNF596 is not targeted by approved drugs and is not considered a therapeutic target in clinical practice[2][3][6][7].
Not applicable; ZNF596 is not a recognized drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 596 (ZNF596).